FindTrial
Sign In

Evaluation of Virtual Reality Headsets on Cancer Patients During Day Hospital Stay

Prospective Evaluation of Virtual Reality Headsets on Cancer Patients During Day Hospital Stay

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06814912
Acronym
VIRTUEL
Enrollment
100
Registered
2025-02-07
Start date
2024-06-01
Completion date
2025-01-20
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Use of virtula reality headsets during treatment course on day hospitalized cancer patients

Interventions

OTHERSurvey using a questionnaire

virtual reality headset is added during treatment administration. Patient must complete a survey at the end of treatment administration and virtual headset use.

Sponsors

Institut Sainte Catherine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* cancer patients * chemotherapy treatment

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Rate of patients with nausea reduction compared with preview treatment administrationFrom the first chemotherapy injection until the end of chemotherapy injection with the virtual reality headset (at the end of the third cycle; each cycle is 21 days) )survey : improvement of nausea

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026